100 Recruiting Studies Using Cytarabine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Cytarabine
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Acute Myeloid Leukemia
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Liver Lymphoma
View Study & Checklist ➔A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia
📍 Children's Hospital of Central California — Madera, California
Acute Myeloid Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Primary Central Nervous System Lymphoma
View Study & Checklist ➔Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
View Study & Checklist ➔Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
📍 City of Hope — Duarte, California
Acute Myeloid Leukemia
View Study & Checklist ➔BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
View Study & Checklist ➔Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Lymphoma
View Study & Checklist ➔Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
📍 UC San Diego Moores Cancer Center — La Jolla, California
HIV Infection
View Study & Checklist ➔Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Mantle Cell Lymphoma
View Study & Checklist ➔Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
📍 University of Florida — Gainesville, Florida
Acute Myeloid Leukemia
View Study & Checklist ➔Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
📍 Loma Linda University Cancer Center — Loma Linda, California
Acute Myeloid Leukemia
View Study & Checklist ➔A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
📍 The University of Alabama at Birmingham — Birmingham, Alabama
Leukemia, Myeloid, Acute
View Study & Checklist ➔Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Blastoid Variant Mantle Cell Lymphoma
View Study & Checklist ➔Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
📍 O'Neal Comprehensive Cancer Center — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Acute Myeloid Leukemia
View Study & Checklist ➔Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML
📍 University of Chicago — Chicago, Illinois
Acute Myeloid Leukemia
View Study & Checklist ➔Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Myeloid Leukemia Post Cytotoxic Therapy
View Study & Checklist ➔Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
📍 Rady Children's Hospital-San Diego — San Diego, California
Acute Leukemia of Ambiguous Lineage in Relapse
View Study & Checklist ➔A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Leukemia
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia
📍 Los Angeles General Medical Center — Los Angeles, California
Acute Myeloid Leukemia
View Study & Checklist ➔Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Central Nervous System Lymphoma
View Study & Checklist ➔Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
📍 Boston Children's Hospital — Boston, Massachusetts
Acute Lymphoblastic Leukemia, Pediatric
View Study & Checklist ➔Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
📍 Hospital Aleman — Ciudad Autonoma de Buenos Aires, Buenos Aires
B-Cell Non-Hodgkin Lymphoma (B-NHL)
View Study & Checklist ➔Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation
📍 City of Hope — Duarte, California
Newly Diagnosed Acute Myeloid Leukemia (AML)
View Study & Checklist ➔Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
📍 University of Arizona Cancer Center - North Campus — Tucson, Arizona
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
View Study & Checklist ➔Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
📍 Colorado Blood Cancer Institute — Denver, Colorado
Autoimmune Disease
View Study & Checklist ➔Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients
📍 Comprehensive Cancer Center of Wake Forest University — Winston-Salem, North Carolina
Untreated Adult Acute Myeloid Leukemia
View Study & Checklist ➔A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham — Birmingham, Alabama
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Recurrent Acute Myeloid Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
📍 Children's Hospital Los Angeles — Los Angeles, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Refractory Acute Lymphoblastic Leukemia
View Study & Checklist ➔Flotetuzumab for the Treatment of Pediatric Recurrent or Refractory Acute Myeloid Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent Acute Myeloid Leukemia
View Study & Checklist ➔Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
📍 Mount Sinai Hospital — New York, New York
Mantle Cell Lymphoma
View Study & Checklist ➔Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent Acute Leukemia of Ambiguous Lineage
View Study & Checklist ➔Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Acute Myeloid Leukemia
View Study & Checklist ➔Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia
📍 Lafayette Family Cancer Center-EMMC — Brewer, Maine
Acute Myeloid Leukemia
View Study & Checklist ➔High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Non-Hodgkin's Lymphoma
View Study & Checklist ➔Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
Mantle Cell Lymphoma
View Study & Checklist ➔Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML
📍 UT MD Anderson — Houston, Texas
Myeloid Leukemia
View Study & Checklist ➔Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
📍 Houston Methodist Neal Cancer Center — Houston, Texas
Acute Myeloid Leukemia (AML)
View Study & Checklist ➔Lazarus: IT Therapy for ICANS
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
Non-hodgkin Lymphoma
View Study & Checklist ➔A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia (AML)
View Study & Checklist ➔A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
📍 Mayo Clinic - Phoenix — Phoenix, Arizona
Acute Myeloid Leukemia
View Study & Checklist ➔Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
📍 University of Miami Miller School of Medicine-Sylvester Cancer Center — Miami, Florida
Acute Monocytic Leukemia
View Study & Checklist ➔Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
📍 University of Chicago Medical Center — Chicago, Illinois
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
📍 Montefiore Einstein Cancer Center and Children's Hospital at Montefiore (CHAM) — The Bronx, New York
Acute Myeloid Leukemia
View Study & Checklist ➔Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Acute Myeloid Leukemia
View Study & Checklist ➔Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
📍 Novant Health Presbyterian Hemby Children's Hospital — Charlotte, North Carolina
Acute Lymphoblastic Leukemia
View Study & Checklist ➔UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML
📍 Texas Children's Cancer and Hematology Center — Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist ➔Revumenib in Combination With 7+3 + Midostaurin in AML
📍 Yale Cancer Center — New Haven, Connecticut
Acute Myeloid Leukemia
View Study & Checklist ➔Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
📍 Mayo Clinic Health Systems-Mankato — Mankato, Minnesota
Clonal Cytopenia of Undetermined Significance
View Study & Checklist ➔Venetoclax to Augment Epigenetic Modification and Chemotherapy
📍 Children's Wisconsin — Milwaukee, Wisconsin
Acute Myeloid Leukemia, in Relapse
View Study & Checklist ➔Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Leukemia
View Study & Checklist ➔Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
📍 Mayo Clinic Arizona — Phoenix, Arizona
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
View Study & Checklist ➔Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Acute Biphenotypic Leukemia
View Study & Checklist ➔Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations
📍 MD Anderson Cancer Center — Houston, Texas
Targeted Therapy
View Study & Checklist ➔A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
📍 Phoenix Children's Hospital — Phoenix, Arizona
Leukemia, Juvenile Myelomonocytic
View Study & Checklist ➔Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia
View Study & Checklist ➔Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
📍 Rady Children's Hospital — San Diego, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
📍 Masonic Cancer Center — Minneapolis, Minnesota
Autologous Stem Cell Transplant
View Study & Checklist ➔Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
📍 Rady Children's Hospital — San Diego, California
T-cell Acute Lymphoblastic Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
📍 UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California
Acute Myeloid Leukemia
View Study & Checklist ➔Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Acute Myeloid Leukemia
View Study & Checklist ➔Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
📍 OHSU Knight Cancer Institute — Portland, Oregon
Acute Myeloid Leukemia
View Study & Checklist ➔Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Down Syndrome
View Study & Checklist ➔Venetoclax Basket Trial for High Risk Hematologic Malignancies
📍 University of California San Francisco-Benioff Children's Hospital — San Francisco, California
Myelodysplastic Syndromes, de Novo
View Study & Checklist ➔Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
📍 Rady Children's Hospital — San Diego, California
Refractory Acute Myeloid Leukemia
View Study & Checklist ➔Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
📍 M D Anderson Cancer Center — Houston, Texas
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
View Study & Checklist ➔A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts
📍 M D Anderson Cancer Center — Houston, Texas
Myelodysplastic Syndromes
View Study & Checklist ➔Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
📍 Memorial Hospital West — Pembroke Pines, Florida
Core Binding Factor Acute Myeloid Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
📍 City of Hope at Phoenix — Phoenix, Arizona
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist ➔A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
📍 Children's Hospital Los Angeles — Los Angeles, California
Relapsed/Refractory KMT2A-r Acute Leukemia
View Study & Checklist ➔Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
📍 M D Anderson Cancer Center — Houston, Texas
Blastic Plasmacytoid Dendritic Cell Neoplasm
View Study & Checklist ➔Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
📍 Children's Hospital Los Angeles — Los Angeles, California
Hematologic Malignancy
View Study & Checklist ➔Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
📍 Alberta Children's Hospital — Calgary, Alberta
CNS Embryonal Tumor
View Study & Checklist ➔